3D-FAA63168 - 3-24-dihydroxyphenylpropionic-acid
3-(3,4-Dihydroxyphenyl)propanoic acid
CAS:Formel:C9H10O4Reinheit:98%Farbe und Form:SolidMolekulargewicht:182.17332,3-Dihydroxy-benzenepropanoic acid
CAS:Formel:C9H10O4Reinheit:95%Farbe und Form:SolidMolekulargewicht:182.17333,3,3-trideuterio-2-[dideuterio-(3,4-dihydroxyphenyl)methyl]-2-hydrazinylpropanoic acid
CAS:Formel:C10H14N2O4Reinheit:99%Farbe und Form:SolidMolekulargewicht:226.2292(2RS)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic Acid (rac-Carbidopa)
CAS:Farbe und Form:NeatTolfenpyrad
CAS:Kontrolliertes ProduktStability Hygroscopic
Applications An inhibitor of aromatic amino acid decarboxylase.
References Sletzinger, M., et al.: J. Med. Chem., 6, 101 (1963)Formel:C10H14N2O4Farbe und Form:Light YellowMolekulargewicht:226.23(S)-(-)-Carbidopa
CAS:Kontrolliertes ProduktStability Unstable in Solution
Applications (S)-(-)-Carbidopa is a peripheral decarboxylase inhibitor that is commonly used in combination with L-DOPA (D533751) for treatment of Parkinsonism. S(-)-Carbidopa ( has also been shown to prolong the elimination half-life of L-DOPA from blood plasma and skeletal muscle.
References Henry, G.M. et al.: Psychosom. Med., 38, 95 (1976); Leguire, L.E. et al.: Invest. Ophthalmol. Vis. Sci. 34, 3090 (1993); Deleu, D. et al.: Naun. Schmied. Arch. Pharmacol. 348: 576 (1993);Formel:C10H14N2O4Farbe und Form:NeatMolekulargewicht:226.23Des-hydrazino Carbidopa
CAS:Applications A metabolite of Carbidopa (C175915).
References Vickers, S., et al.: Drug Metab. Dispos., 2, 6 (1974), Vickers, S., et al.: J. Med. Chem., 18, 134 (1975),Formel:C10H12O4Farbe und Form:NeatMolekulargewicht:196.23-(3,4-Dihydroxyphenyl)-2-methylpropanoic acid
CAS:3-(3,4-Dihydroxyphenyl)-2-methylpropanoic acid
Reinheit:98%2-Methyl-3-(3,4-dihydroxyphenyl)propanoic acid
CAS:2-Methyl-3-(3,4-dihydroxyphenyl)propanoic acid (DOPA) is a prodrug that is converted to the active form 2-methyl-5,6-dihydroxyindole-3,4-dione (DIDO) by hydrazine. DIDO inhibits melanoma cells by binding to tyrosinase and inhibiting its activity. DOPA also has cytotoxic properties, which may be due to the production of oxidative metabolites such as hydrogen peroxide and free radicals. DIDO can also be metabolized into catechol and cyclized into quinone methides. DOPA can inhibit oxidation reactions in the cell line CCRF-CEM by preventing the oxidation of NADH to NAD+.Formel:C10H12O4Reinheit:Min. 95%Farbe und Form:PowderMolekulargewicht:196.2 g/molCarbidopa Monohydrate
CAS:Formel:C10H14N2O4·H2OReinheit:>98.0%(T)(HPLC)Farbe und Form:White to Light yellow powder to crystalineMolekulargewicht:244.253-(2,4-Dihydroxyphenyl)propanoic acid
CAS:Formel:C9H10O4Reinheit:98%Farbe und Form:SolidMolekulargewicht:182.1733rac-Carbidopa-13C-d3
CAS:Formel:C913CH11D3N2O4Farbe und Form:White To Off-White SolidMolekulargewicht:230.243-(2,4-Dihydroxyphenyl)propanoic acid
CAS:3-(2,4-Dihydroxyphenyl)propanoic acidReinheit:≥98%Molekulargewicht:182.17g/mol(S)-3-(3,4-Dihydroxyphenyl)-2-Hydrazinyl-2-Methylpropanoic Acid
CAS:(S)-3-(3,4-Dihydroxyphenyl)-2-Hydrazinyl-2-Methylpropanoic AcidReinheit:97%Molekulargewicht:226.23g/mol3-(2,4-Dihydroxyphenyl)Propionic Acid
CAS:3-(2,4-Dihydroxyphenyl)Propionic AcidReinheit:97%Molekulargewicht:182.17g/mol3-(2,4-Dihydroxyphenyl)propionic acid
CAS:Formel:C9H10O4Reinheit:95%~99%Farbe und Form:PowderMolekulargewicht:182.175
![3,3,3-trideuterio-2-[dideuterio-(3,4-dihydroxyphenyl)methyl]-2-hydrazinylpropanoic acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb-webp%2FDA00I5DW.webp&w=3840&q=75)
